1. ANSI/AAMI HE75, 2009/(R)2013 Human factors engineering—design of medical devices.
2. Khassawneh BY, Al-Ali MK, Alzoubi KH, Batarseh MZ, Al-Safi SA, Sharara AM, et al. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. Respir Care. 2008;53(3):324–8.
3. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Aldo CP, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93(4):439–46.
4. Thomas M, Price D, Chrystyn H, Lloyd A, Williams AE, von Ziegenweidt J. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med. 2009;9:1. doi: 10.1186/1471-2466-9-1 .
5. Seebri® Breezhaler®, EMA summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002430/WC500133769.pdf . Accessed 28 Aug 2014.